Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia	Hemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Neoplasms by Histologic Type, T-cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1 / Phase 2	2025-04-30		NCT05863234

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hiroshima University Hospital	1
Hokkaido University Hospital	4
Komagome Hospital	1
Kyoto University Hospital	2
Kyushu University	6
Nagoya University	3
Okayama University	4
Tohoku University	5
Tokai University	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hiroshima University Hospital	Hiroshima	Japan	15